EBS - Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript
2024-05-01 21:38:11 ET
Emergent BioSolutions Inc. (EBS)
Q1 2024 Earnings Call Transcript
May 01, 2024, 05:00 PM ET
Company Participants
Joe Papa - President and CEO
Rich Lindahl - EVP and CFO
Paul Williams - SVP, Products Business
Presentation
Operator
Good afternoon, everyone. I'm the operator for today's call. Thank you for joining today as Emergent discusses their operational and financial results for the first quarter of 2024. As is customary, today's call is open to all participants, and the call is being recorded and is copyrighted by Emergent BioSolutions. In addition to today's press release, there is a series of slides accompanying this webcast available to all webcast participants.
Turning to Slide 3. During today's call, Emergent may make projections and other forward-looking statements related to their business, future events, their prospects or future performance. These forward-looking statements are based on their current intentions, beliefs and expectations regarding future events. Any forward-looking statement speaks only as of the date of this conference call and except as required by law, Emergent does not undertake to update any forward-looking statements to reflect new information, events or circumstances. Investors should consider this cautionary statement as well as the risk factors identified in Emergent's periodic reports filed with the SEC when evaluating their forward-looking statements. During today's call, Emergent may also discuss certain non-GAAP financial measures that involve adjustments to GAAP figures in order to provide greater transparency regarding Emergent's operating performance. Please refer to the tables found in today's press release....
Emergent BioSolutions Inc. (EBS) Q1 2024 Earnings Call Transcript